Pertento Partners LLP Buys New Position in Nutex Health Inc. $NUTX

Pertento Partners LLP purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 270,421 shares of the company’s stock, valued at approximately $27,940,000. Nutex Health comprises about 3.2% of Pertento Partners LLP’s holdings, making the stock its 13th biggest holding. Pertento Partners LLP owned approximately 4.87% of Nutex Health as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. State of Alaska Department of Revenue purchased a new stake in shares of Nutex Health in the third quarter valued at about $30,000. BNP Paribas Financial Markets grew its position in Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after purchasing an additional 290 shares in the last quarter. Ameritas Investment Partners Inc. bought a new stake in Nutex Health in the 2nd quarter worth about $44,000. Bank of America Corp DE increased its stake in Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after buying an additional 2,043 shares during the last quarter. Finally, Police & Firemen s Retirement System of New Jersey bought a new position in shares of Nutex Health during the 2nd quarter worth approximately $97,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Stock Performance

Shares of NUTX stock opened at $90.49 on Thursday. The firm has a market cap of $630.72 million, a price-to-earnings ratio of 10.08 and a beta of 0.03. The company has a debt-to-equity ratio of 0.70, a quick ratio of 3.39 and a current ratio of 3.41. Nutex Health Inc. has a 52 week low of $43.81 and a 52 week high of $193.07. The firm’s 50-day simple moving average is $131.77 and its two-hundred day simple moving average is $124.74.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Thursday, March 5th. The company reported $1.61 earnings per share for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95). Nutex Health had a net margin of 7.34% and a return on equity of 17.67%. The company had revenue of $151.68 million for the quarter, compared to the consensus estimate of $258.82 million.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on NUTX. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a research note on Monday, December 29th. Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Saturday, March 7th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Nutex Health has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.